Authors: Anderson, Annie S., Baker, Jennifer L., Bianchini, Franca, Breda, João, Byers, Tim, Clearly, Margot P., Colditz, Graham, Di Cesare, Mariachiara, Gapstur, Susan M., Grosse, Yann, Gunter, Marc, Herbert, Ronald A., Hursting, Stephen D., Kaaks, Rudolf, Lauby-Secretan, Béatrice, Leitzmann, Michael, Ligibel, Jennifer, Loomis, Dana, Renehan, Andrew, Romieu, Isabelle, Scoccianti, Chiara, Shimokawa, Isao, Straif, Kurt, Thompson, Henry J., Ulrich, Cornelia M., Wade, Katlin, Weiderpass, Elisabete
Published: August 24, 2016
The IARC Handbook Working Group identified liver cancer as one of eight newly classified cancer sites with sufficient evidence that absence of excess body fatness lowers cancer risk. Meta-analyses showed relative risks of 1.2 to 1.5 for overweight and 1.5 to 1.8 for obesity, with a pooled relative risk of 1.8 (95% CI, 1.6–2.1) for the highest BMI category versus normal BMI. A significant positive dose-response relationship was documented. Results were consistent across different geographic regions when studies from multiple areas were available. Stratification according to sex generally showed similarly increased risks among men and women. This cancer type was newly added to the list of cancers with sufficient evidence since the previous 2002 IARC evaluation.
